Global On-body Injectors Market Insights, Forecast to 2025

An on-body Injector is a small, lightweight delivery system applied to the skin.
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
The global On-body Injectors market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the On-body Injectors market based on company, product type, end user and key regions.

This report studies the global market size of On-body Injectors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of On-body Injectors in these regions.
This research report categorizes the global On-body Injectors market by top players/brands, region, type and end user. This report also studies the global On-body Injectors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BD Medical
Medtronic
Insulet
Sensile Medical
Ypsomed
Enable Injections
Roche
ScPharmaceuticals
SteadyMed
CeQur
Tandem Diabetes Care
Valeritas
SteadyMed Therapeutics
Amgen

Market size by Product
Electronical Injectors
Mechanical Injectors
Others
Market size by End User
Immuno-oncology
Diabetes
Cardiovascular Diseases
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global On-body Injectors market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of On-body Injectors market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global On-body Injectors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of On-body Injectors submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of On-body Injectors are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of On-body Injectors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 On-body Injectors Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global On-body Injectors Market Size Growth Rate by Product
1.4.2 Electronical Injectors
1.4.3 Mechanical Injectors
1.4.4 Others
1.5 Market by End User
1.5.1 Global On-body Injectors Market Size Growth Rate by End User
1.5.2 Immuno-oncology
1.5.3 Diabetes
1.5.4 Cardiovascular Diseases
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global On-body Injectors Market Size
2.1.1 Global On-body Injectors Revenue 2013-2025
2.1.2 Global On-body Injectors Sales 2013-2025
2.2 On-body Injectors Growth Rate by Regions
2.2.1 Global On-body Injectors Sales by Regions
2.2.2 Global On-body Injectors Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 On-body Injectors Sales by Manufacturers
3.1.1 On-body Injectors Sales by Manufacturers
3.1.2 On-body Injectors Sales Market Share by Manufacturers
3.1.3 Global On-body Injectors Market Concentration Ratio (CR5 and HHI)
3.2 On-body Injectors Revenue by Manufacturers
3.2.1 On-body Injectors Revenue by Manufacturers (2013-2018)
3.2.2 On-body Injectors Revenue Share by Manufacturers (2013-2018)
3.3 On-body Injectors Price by Manufacturers
3.4 On-body Injectors Manufacturing Base Distribution, Product Types
3.4.1 On-body Injectors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers On-body Injectors Product Type
3.4.3 Date of International Manufacturers Enter into On-body Injectors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global On-body Injectors Sales by Product
4.2 Global On-body Injectors Revenue by Product
4.3 On-body Injectors Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global On-body Injectors Breakdown Data by End User

6 North America
6.1 North America On-body Injectors by Countries
6.1.1 North America On-body Injectors Sales by Countries
6.1.2 North America On-body Injectors Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America On-body Injectors by Product
6.3 North America On-body Injectors by End User

7 Europe
7.1 Europe On-body Injectors by Countries
7.1.1 Europe On-body Injectors Sales by Countries
7.1.2 Europe On-body Injectors Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe On-body Injectors by Product
7.3 Europe On-body Injectors by End User

8 Asia Pacific
8.1 Asia Pacific On-body Injectors by Countries
8.1.1 Asia Pacific On-body Injectors Sales by Countries
8.1.2 Asia Pacific On-body Injectors Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific On-body Injectors by Product
8.3 Asia Pacific On-body Injectors by End User

9 Central & South America
9.1 Central & South America On-body Injectors by Countries
9.1.1 Central & South America On-body Injectors Sales by Countries
9.1.2 Central & South America On-body Injectors Revenue by Countries
9.1.3 Brazil
9.2 Central & South America On-body Injectors by Product
9.3 Central & South America On-body Injectors by End User

10 Middle East and Africa
10.1 Middle East and Africa On-body Injectors by Countries
10.1.1 Middle East and Africa On-body Injectors Sales by Countries
10.1.2 Middle East and Africa On-body Injectors Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa On-body Injectors by Product
10.3 Middle East and Africa On-body Injectors by End User

11 Company Profiles
11.1 BD Medical
11.1.1 BD Medical Company Details
11.1.2 Company Business Overview
11.1.3 BD Medical On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.1.4 BD Medical On-body Injectors Products Offered
11.1.5 BD Medical Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Company Business Overview
11.2.3 Medtronic On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Medtronic On-body Injectors Products Offered
11.2.5 Medtronic Recent Development
11.3 Insulet
11.3.1 Insulet Company Details
11.3.2 Company Business Overview
11.3.Insulet On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Insulet On-body Injectors Products Offered
11.3.5 Insulet Recent Development
11.4 Sensile Medical
11.4.1 Sensile Medical Company Details
11.4.2 Company Business Overview
11.4.3 Sensile Medical On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Sensile Medical On-body Injectors Products Offered
11.4.5 Sensile Medical Recent Development
11.5 Ypsomed
11.5.1 Ypsomed Company Details
11.5.2 Company Business Overview
11.5.3 Ypsomed On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Ypsomed On-body Injectors Products Offered
11.5.5 Ypsomed Recent Development
11.6 Enable Injections
11.6.1 Enable Injections Company Details
11.6.2 Company Business Overview
11.6.3 Enable Injections On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Enable Injections On-body Injectors Products Offered
11.6.5 Enable Injections Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Company Business Overview
11.7.3 Roche On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Roche On-body Injectors Products Offered
11.7.5 Roche Recent Development
11.8 ScPharmaceuticals
11.8.1 ScPharmaceuticals Company Details
11.8.2 Company Business Overview
11.8.3 ScPharmaceuticals On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.8.4 ScPharmaceuticals On-body Injectors Products Offered
11.8.5 ScPharmaceuticals Recent Development
11.9 SteadyMed
11.9.1 SteadyMed Company Details
11.9.2 Company Business Overview
11.9.3 SteadyMed On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.9.4 SteadyMed On-body Injectors Products Offered
11.9.5 SteadyMed Recent Development
11.10 CeQur
11.10.1 CeQur Company Details
11.10.2 Company Business Overview
11.10.3 CeQur On-body Injectors Sales, Revenue and Gross Margin (2013-2018)
11.10.4 CeQur On-body Injectors Products Offered
11.10.5 CeQur Recent Development
11.11 Tandem Diabetes Care
11.12 Valeritas
11.13 SteadyMed Therapeutics
11.14 Amgen

12 Future Forecast
12.1 On-body Injectors Market Forecast by Regions
12.1.1 Global On-body Injectors Sales Forecast by Regions 2018-2025
12.1.2 Global On-body Injectors Revenue Forecast by Regions 2018-2025
12.2 On-body Injectors Market Forecast by Product
12.2.1 Global On-body Injectors Sales Forecast by Product 2018-2025
12.2.2 Global On-body Injectors Revenue Forecast by Product 2018-2025
12.3 On-body Injectors Market Forecast by End User
12.4 North America On-body Injectors Forecast
12.5 Europe On-body Injectors Forecast
12.6 Asia Pacific On-body Injectors Forecast
12.7 Central & South America On-body Injectors Forecast
12.8 Middle East and Africa On-body Injectors Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 On-body Injectors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Please Select Format

Single User: US $4900

Enterprise User: US $9800

Enquiry About Report

Need More Information

SIMILAR MARKET STUDIES

ASEAN Blood Pressure Monitoring Devices Market by Product (Aneroid BP Monitors, Digital BP Monitors, and Ambulatory BP Monitors) and Country (Malaysia, Philippines, Vietnam, Thailand, Indonesia and Rest of ASEAN Countries): Opportunity Analysis and Industry Forecast, 2018 - 2025

The ASEAN blood pressure monitoring devices market was valued at $31.5 million in 2017 and is expected to reach $53.3 million by 2025, registering a CAGR of 6.8% from 2018 to 2025. In terms of volume, the ambulatory BP monitors segment is expected to register the highest CAGR of 7.9% from 2018 to 2025.

December 2018 | $3500 |View Details>>

Global Ulnar Nerve Entrapment Market Research Report 2018

This report studies the global Ulnar Nerve Entrapment market status and forecast, categorizes the global Ulnar Nerve Entrapment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers ...

December 2018 | $2900 |View Details>>

Global Spasticity Treatment Market Research Report 2018

This report studies the global Spasticity Treatment market status and forecast, categorizes the global Spasticity Treatment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in ...

December 2018 | $2900 |View Details>>

Global Pharmerging Market Research Report 2018

This report studies the global Pharmerging market status and forecast, categorizes the global Pharmerging market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report ...

December 2018 | $2900 |View Details>>

UPCOMING MARKET RESEARCH REPORTS

World Anesthesia Monitoring Devices Market - Opportunities and Forecasts, 2014 - 2020

Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patients oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.